SEC Form D · filed November 19, 2018
ZIOPHARM ONCOLOGY INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Laurence J. Cooper · Boston, MAExec · DirectorScott W. Tarriff · Boston, MADirectorJames A. Cannon · Boston, MADirectorKevin G. Lafond · Boston, MAExecDouglas W. Pagan · Boston, MADirectorRobert W. Hadfield · Boston, MAExecScott G. Braunstein · Boston, MADirectorDavid W. Mauney · Boston, MAExecElan Z. Ezickson · Cambridge, MADirectorDawn Howe · Grand Cayman, Cayman IslandsDirectorStephen J. Ketchum · New York, NYDirectorMurat Ozbaydar · New York, NYExecJohn J. Tobin · Seattle, WADirectorBradford G. Jackson · Seattle, WAExecAravt Global LLC · New York, NYDirectorEd Braswell · Brentwood, TNExec · DirectorUmit Alptuna · New York, NYExecBill Sasser · Brentwood, TNDirectorJames D. Mitchell · Seattle, WAExecMatthew Zalosh · Boston, MADirectorArthur N. Budge, Jr · CAMARILLO, CAExec · DirectorAli Hamed · New York, NYDirectorYieldStreet Management LLC · New York, NYDirectorRob Heyvaert · NEW YORK, NYExecKristy R. Trieste · NEW YORK, NYDirectorMark R. Kessler · New York, NYExecJason K. Mendelson · Boulder, CODirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗